Drug Information

Drug General Information
Drug ID
D0P2ZY
Former ID
DNCL002226
Drug Name
INNO-305
Indication Acute myeloid leukemia; Lung cancer [ICD9: 205, 162; ICD10:C92.0, C33-C34] Phase 1 [548250]
Company
CytRx
Target and Pathway
Target(s) Wilms' tumor protein Target Info Modulator [548249]
KEGG Pathway Transcriptional misregulation in cancer
NetPath Pathway FSH Signaling Pathway
IL5 Signaling Pathway
Pathway Interaction Database p73 transcription factor network
Regulation of Telomerase
WikiPathways Primary Focal Segmental Glomerulosclerosis FSGS
Integrated Pancreatic Cancer Pathway
References
Ref 548250Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023753)
Ref 548249Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023753)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.